tiprankstipranks
GlaxoSmithKline (GSK)
NYSE:GSK
US Market
GSK
GlaxoSmithKline
RESEARCH TOOLSreports

GlaxoSmithKline (GSK) Stock News & Sentiment

5,219 Followers
“A Blockbuster? Yes, Absolutely” — GlaxoSmithKline (GSK) Stock Slides despite Morez Hype
Premium
Market News
“A Blockbuster? Yes, Absolutely” — GlaxoSmithKline (GSK) Stock Slides despite Morez Hype
8h ago
GSK
GSK’s New Cancer Drug GSK5533524 Enters First‑in‑Human Testing: What Investors Should Watch
Premium
Company Announcements
GSK’s New Cancer Drug GSK5533524 Enters First‑in‑Human Testing: What Investors Should Watch
7d ago
GSK
GSK’s New Efimosfermin Alfa Trial Signals Renewed Push Into Fatty Liver Disease
Premium
Company Announcements
GSK’s New Efimosfermin Alfa Trial Signals Renewed Push Into Fatty Liver Disease
17d ago
GSK
M&A News: Gilead Bets $2B+ on Ouro Medicines to Power Immunology Growth
Premium
Market News
M&A News: Gilead Bets $2B+ on Ouro Medicines to Power Immunology Growth
21d ago
GSK
GILD
GSK Advances New Phase 3 Trial in Hard-to-Treat Ovarian Cancer: What Investors Should Watch
Premium
Company Announcements
GSK Advances New Phase 3 Trial in Hard-to-Treat Ovarian Cancer: What Investors Should Watch
25d ago
GSK
GSK Wins First U.S. Approval for Lynavoy in PBC-Related Itch, Advancing Hepatology Push
Premium
Company Announcements
GSK Wins First U.S. Approval for Lynavoy in PBC-Related Itch, Advancing Hepatology Push
25d ago
6K
GSK
GSK Discloses Chief People Officer’s March 16 ADS Purchase Under Pension Plan
Premium
Company Announcements
GSK Discloses Chief People Officer’s March 16 ADS Purchase Under Pension Plan
26d ago
6K
GSK
More GSK News >

GSK News on the Web

GSK presents data from its phase I Behold-1 trial for Mo-Rez
TipRanks News
Bullish
GlaxoSmithKline (GSK) Receives a Buy from Jefferies
TipRanks News
Bearish
“A Blockbuster? Yes, Absolutely” — GlaxoSmithKline (GSK) Stock Slides despite Morez Hype
TipRanks News
Neutral
Goldman Sachs Sticks to Their Hold Rating for GlaxoSmithKline (GSK)
TipRanks News
Bearish
GSK Announces Positive Phase I Results For Mo-Rez In Ovarian And Endometrial Cancer
rttnews
Bullish
GSK Shifts Strategy with Five Late-Stage Trials for Promising Cancer Drug
GuruFocus News
Bullish
Why GSK (GSK) is a Top Momentum Stock for the Long-Term
Zacks
Bullish
UBS Remains a Hold on GlaxoSmithKline (GSK)
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
GSK
Sector Average
Media Buzz
This Week16 articles
Weekly Average15 articles
News Sentiment
This Week50%
Sector Average69%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GSK’s Media Buzz Sentiment?
16 articles about GSK were published this week. In an average week, 15 articles are published.
    What is GSK’s weekly average amount of articles?
    In an average week, 15 articles about GSK are published.
      What is GSK’s News Sentiment?
      50% of articles about GSK were positive this week, compared to its sector average of 69%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        STAAStaar Surgical
        IVVDInvivyd
        REPLReplimune Group
        SLPSimulations Plus
        Showing the stocks with the most bullish news sentiment over the past week